Squarepoint Ops LLC Madrigal Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$193.33 - $291.99 $999,516 - $1.51 Million	5,170 New	5,170 $1.45 Million
Q4 2022 Feb 14, 2023	BUY	$58.39 - $296.54 $171,199 - $869,455	2,932 New	2,932 $851,000
Q2 2022 Aug 15, 2022	BUY	$58.04 - $100.2 $236,454 - $408,214	4,074 New	4,074 $292,000
Q1 2022 May 16, 2022	SELL	$55.89 - $101.89 $1.28 Million - $2.33 Million	-22,827 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$72.34 - $95.09 $888,913 - $1.17 Million	-12,288 Reduced 34.99%	22,827 $1.93 Million
Q3 2021 Nov 15, 2021	BUY	$78.35 - $105.02 $198,068 - $265,490	2,528 Added 7.76%	35,115 $2.8 Million
Q2 2021 Aug 16, 2021	BUY	$97.2 - $137.59 $1.28 Million - $1.81 Million	13,123 Added 67.42%	32,587 $3.17 Million
Q1 2021 May 17, 2021	BUY	$108.54 - $125.2 $1.77 Million - $2.05 Million	16,352 Added 525.45%	19,464 $2.28 Million
Q4 2020 Feb 16, 2021	SELL	$110.06 - $133.7 $180,608 - $219,401	-1,641 Reduced 34.53%	3,112 $346,000
Q3 2020 Nov 16, 2020	BUY	$99.78 - $124.21 $175,912 - $218,982	1,763 Added 58.96%	4,753 $564,000
Q2 2020 Aug 14, 2020	BUY	$60.13 - $125.71 $179,788 - $375,872	2,990 New	2,990 $339,000
Q1 2020 May 15, 2020	SELL	$66.76 - $93.49 $1.42 Million - $1.99 Million	-21,301 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$84.28 - $118.5 $1.47 Million - $2.06 Million	17,409 Added 447.3%	21,301 $1.94 Million
Q3 2019 Nov 14, 2019	BUY	$84.4 - $106.53 $328,484 - $414,614	3,892 New	3,892 $336,000
Q2 2019 Aug 14, 2019	SELL	$91.13 - $142.5 $209,599 - $327,750	-2,300 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$103.48 - $143.84 $17,798 - $24,740	-172 Reduced 6.96%	2,300 $288,000
Q4 2018 Feb 14, 2019	SELL	$94.77 - $215.54 $149,641 - $340,337	-1,579 Reduced 38.98%	2,472 $279,000
Q3 2018 Nov 14, 2018	BUY	$207.3 - $300.31 $508,092 - $736,059	2,451 Added 153.19%	4,051 $867,000
Q2 2018 Aug 14, 2018	SELL	$101.55 - $313.9 $222,597 - $688,068	-2,192 Reduced 57.81%	1,600 $448,000
Q1 2018 May 15, 2018	SELL	$93.35 - $149.04 $12,415 - $19,822	-133 Reduced 3.39%	3,792 $443,000
Q4 2017 Feb 14, 2018	BUY	$39.35 - $97.37 $154,448 - $382,177	3,925	3,925 $360,000

Others Institutions Holding MDGL

# of Institutions

298

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

Janus Henderson Group PLC London, X0

2.48M
Shares

$855 Million
0.28% of portfolio
John Paulson Paulson & Co. Inc. | New York, Ny

2.04M
Shares

$705 Million
29.57% of portfolio
Avoro Capital Advisors LLC New York, NY

2.03M
Shares

$700 Million
6.48% of portfolio
Rtw Investments, LP New York, NY

1.99M
Shares

$688 Million
6.74% of portfolio
Baker Bros. Advisors LP New York, NY

1.97M
Shares

$682 Million
4.49% of portfolio

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.9B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account